Insights from immuno-oncology: The Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

Paolo Antonio Ascierto, Bernard Fox, Walter Urba, Ana Carrizosa Anderson, Michael B. Atkins, Ernest C. Borden, Julie Brahmer, Lisa H. Butterfield, Alessandra Cesano, Daniel Chen, Tanja De Gruijl, Robert O. Dillman, Charles G. Drake, Leisha A. Emens, Thomas F. Gajewski, James L. Gulley, F. Stephen Hodi, Patrick Hwu, David Kaufman, Howard KaufmanMichael Lotze, Douglas G. McNeel, Kim Margolin, Francesco Marincola, Michael J. Mastrangelo, Marcela V. Maus, David R. Parkinson, Pedro J. Romero, Paul M. Sondel, Stefani Spranger, Mario Sznol, George J. Weiner, Jon M. Wiggington, Jeffrey S. Weber*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Article numbere000878
JournalJournal for Immunotherapy of Cancer
Volume8
Issue number1
DOIs
Publication statusPublished - 16 Apr 2020

Cite this